Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
See more at ABC News
Uncensored Image Generator
Twitter
Telegram
Facebook
Copy to clipboard
Breaking
Riot Platforms, Core Scientific earnings, U.S. jobs report: Crypto Week Ahead
Your look at what's coming in the week starting March 2....
20 minutes ago
·
CoinDesk
Clinton Deposition in Epstein Probe Shatters Congressional Norms
Snow blanketed a quiet New York village as lawmakers carried out a step many historians say had never happened before....
40 minutes ago
·
Independent Journal Review
Hezbollah leader killed in IDF strikes in Lebanon
The Hezbollah leader of a Lebanese parliamentary bloc was killed on Sunday in air strikes conducted by the IDF....
44 minutes ago
·
Washington Examiner
Modal title
×
Modal body text goes here.
Dissenter Trends
Trends Home
Search
Uncensored Image Generator ➜
loading...